Authors


Madelyn Stabinski, PharmD Candidate, Duquesne University, Jonathan Ogurchak, PharmD, CSP

Latest:

Repatha: A Lipid-lowering Monoclonal Antibody

Evolocumab, when used with diet, can be used as monotherapy or in combination with other lipid-lowering agents for the prevention of cardiovascular events.



Dava Stewart

Latest:

Buprenorphine Treatment Linked to Depression, Sleep Disruption

Opioid therapies are often prescribed for sleep disturbance due to their effect on multiple neurochemical pathways associated with sleep.



Max Sow, MBA

Latest:

Electronic Prescribing of Controlled Substances: A Tool to Help Promote Better Patient Care

This study presents the first information available regarding enablement and use by state and area characteristics of electronic prescribing of controlled substances by prescribers and pharmacy systems in from an e-prescribing network.


Jacobo de Silva Urquijo

Latest:

Together Beyond COVID-19: A Look at the Future of the Pharmaceutical Industry

In a short time, COVID-19 has increased our dependency on technology and pharmaceutical companies are actively investigating this digital transformation.


Gavin Magaha, PharmD, MS

Latest:

340B Compliance: The Medicaid Exclusion File and Prevention of Duplicate Discounts

Health care providers participating in the 340B program are prohibited from contributing to duplicate discounts, or the scenario that exists when a manufacturer provides a discounted 340B price and a rebate to Medicaid for the same drug.


John F. Trowbridge, MD

Latest:

Antimicrobial Stewardship at the Tipping Point

Antimicrobial stewardship programs have been around for some time. However, a tipping point has yet to be achieved where most hospitals and long-term care facilities have effective programs.


Margaret K. Pasquale, PhD

Latest:

Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy

This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.


Cheryl Allen, BSPharm, MBA

Latest:

Seven Essential Points to Position Specialty Pharmacies for Limited-Distribution Agents

Position your specialty pharmacy to access limited distribution drugs.


Susan R. Rose, MD

Latest:

Growth Hormone Therapy Guidelines: Clinical and Managed Care Perspectives

Current treatment guidelines utilized by healthcare provider organizations and managed care organization insurance coverage policies for growth hormone therapy are reviewed.


Deborah Bell

Latest:

Jumping Through Hoops and Over Hurdles

Gaining approval from insurance companies for highly effective new hepatitis C virus treatments is fraught with challenges for patients.



Debra Freiheit, RPh

Latest:

Acute Coronary Syndrome: How to Empower Patients

Patients with a new diagnosis of acute coronary syndrome often do not know a great deal about their disease, its treatment, or the lifestyle changes needed to prevent recurrence.


Crystal R. Maas-Patel, PharmD

Latest:

Recent Trends in the Treatment of Chronic Hepatitis C

This article is an early utilization review of newer, more effective, and more costly regimens for the treatment of hepatitis C.


Mary K. Caffrey

Latest:

Repatha Gets Early Thumbs Down by Britain's NICE

The action by NICE highlights discussion on both sides of the Atlantic about the cost of PCSK9 inhibitors, which lower LDL cholesterol.


Dennis Williams, PharmD, BCPS, AE-C

Latest:

COPD: Improving Disease Management

Effective management of COPD can improve quality of life for patients and help reduce rehospitalizations.


Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP

Latest:

Specialty Drugs: Year in Review 2017 Part II

The second part of a comprehensive review of the specialty pharmaceuticals approved by the FDA in 2017.


Omama Zubairi, PharmD Candidate

Latest:

Acute Pain Management in the General Population

Acute pain is one of the most common complaints that lead Americans to access the health care system, resulting in more than 115 million emergency department visits each year.


William L. Musick, PharmD, BCPS (AQ-ID)

Latest:

Tuberculosis: The Consuming Plague

The development of multidrug-resistant and extensively drug-resistant tuberculosis in recent decades has made treatment challenging.


Wing Chan, MS

Latest:

Patient Preference for Treatment Administration in Cystic Fibrosis

This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.


Hiba Takieddin, PharmD

Latest:

The Role of Sleep in Infant Development

Studies have shown that sleep benefits infants’ memories and general cognitive and emotional development.


Elaine Nguyen, PharmD, MPH

Latest:

Case Studies (May 2016)

What should these pharmacists do?


Diana M. Sobieraj, PharmD

Latest:

Case Studies (May 2015)

What should these pharmacists do?



Shonda Foster, MS, PharmD

Latest:

Daily Dose and Costs of Therapy With Topical Testosterone Agents

We assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.


Ryan Sanok, PharmD Candidate

Latest:

Get PrEPared for HIV Prophylaxis

Expansion to adolescents, flexible dosing strategies, innovative delivery models, and long-acting antiretrovirals all help the strategy.


Olivia C. Welter, PharmD Candidate 2021

Latest:

Age-related Memory Loss: Dietary Changes Can Have Positive Impact

As misconceptions surround some OTC supplements, changes to the diet may be beneficial in supporting brain health in populations experiencing age-related memory loss.


Alice Kate Cummings, BA

Latest:

Do Units and Costs of Comparable Insulins Differ by Manufacturer?

Patient characteristics and product mix play an important role in determining the overall use and costs of comparable insulins across different manufacturers.


Marcus Silva, PharmD Candidate, Jonathan Jackson, PharmD

Latest:

Ethical Issues in Pharmacogenomics

The clinical implementation of pharmacogenomics is an exciting area that is showing promise of enhancing the quality of patient care.